Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience

被引：0
|
作者：
Ghamsari, Farid [1 ]
Trando, Aaron [2 ]
Medley, Katherine [3 ]
Martino, Janine [3 ]
Block, Shanna [3 ]
Wells, Kaitlyn [3 ]
Doan, Thu [3 ]
Quach, Anthony [3 ]
Cheng, Renee [4 ]
Costello, Caitlin [1 ]
Jeong, Autumn [5 ]
Saunders, Ila [6 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] UCSD Sch Med, San Diego, CA USA
[3] UCSD Hlth, Dept Pharm, San Diego, CA USA
[4] UCSD Hematol Oncol Fellowship Program, San Diego, CA USA
[5] UCSD Div Blood & Bone Marrow Transplantat, San Diego, CA USA
[6] UCSD Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-025
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience
    Ghamsari, Farid
    Trando, Aaron
    Medley, Katherine
    Martino, Janine
    Block, Shanna
    Doan, Thu
    Wells, Kaitlyn
    Quach, Anthony C.
    Cheng, Renee Gong
    Costello, Caitlin
    Jeong, Ah-Reum
    Saunders, Ila M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
    Stepanovic, Adam
    Abonour, Rafat
    Abu Zaid, Mohammad
    Farag, Sherif
    Lee, Kelvin P.
    Suvannasankha, Attaya
    BLOOD, 2023, 142
  • [3] Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Popat, Rakesh
    Martinez-Lopez, Joaquin
    Kastritis, Efstathios
    Brunaldi, Larissa
    Bansal, Radhika
    Corraes, Andre De Menezes Silva
    Yong, Kwee
    Mactier, Catriona
    Corona, Magdalena
    Saez Marin, Adolfo Jesus
    Fotiou, Despina
    Dimopoulos, Meletios Athanasios
    Chhabra, Saurabh
    Ailawadhi, Sikander
    Parrondo, Ricardo
    Martin, Thomas
    Durie, Brian G. M.
    Lin, Yi
    BLOOD, 2023, 142
  • [4] Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
    Uttervall, Katarina
    Nahi, Hareth
    Kashif, Muhammad
    Lemonakis, Konstantinos
    Rosengren, Sara
    Brolin, Janaki
    Lund, Johan
    Hansson, Markus
    BLOOD, 2022, 140 : 12605 - 12606
  • [5] Safety and Efficacy of Teclistamab in Patients with Relapsed/ Refractory Multiple Myeloma: A Real-World Experience
    Dima, Danai
    Davis, James A.
    Ahmed, Nausheen
    Jia, Xuefei
    Sannareddy, Aishwarya
    Shaikh, Hira
    Shune, Leyla
    Kaur, Gurbakhash
    Khouri, Jack
    Afrough, Aimaz
    Strouse, Christopher
    Lochner, Jonathan
    Mahmoudjafari, Zahra
    Raza, Shahzad
    Valent, Jason
    Anderson Jr, Larry D.
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 308.e1 - 308.e13
  • [6] Real-World Clinical Outcomes of Teclistamab and Talquetamab in Relapsed/Refractory Multiple Myeloma (RRMM): A UK Single-Centre Experience
    Feixas, Pablo Tenorio
    Cox, Catrin
    Peer, Xavier
    Cuthill, Kirsty
    Benjamin, Reuben
    Gunawan, Arief
    Cuadrado, Maria
    de Farias, Madson Correia
    Jones, John
    Shin, Jin-Sup
    Batool, Asma
    Bowcock, Stella
    Omer, Musab
    Tawde, Prachi
    Bailey, Katharine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S92 - S92
  • [7] Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
    Razzo, Beatrice
    Grajales-Cruz, Ariel
    Atrash, Shebli
    Ferreri, Christopher
    Goyal, Anmol
    Pasvolsky, Oren
    Banerjee, Rahul
    Julian, Kelley
    Forsberg, Peter
    Herr, Megan
    Lin, Yi
    Susanibar-Adaniya, Sandra
    Khouri, Jack
    Vazquez-Martinez, Mariola
    Lee, Hans
    Portuguese, Andrew
    Sborov, Douglas W.
    Dima, Danai
    Davis, James
    Kaur, Gurbakhash
    Shune, Leyla
    Hansen, Doris
    Sidana, Surbhi
    Garfall, Alfred
    Richard, Shambavi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S82 - S83
  • [8] Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)
    Maringanti, Sireesha Asoori
    Lin, Yi
    Estritis, Stathis
    Martinez-Lopez, Joaquin
    Bansal, Radhika
    Fotiou, Despina
    Corona, Magdalena
    Chhabra, Saurabh
    Brunaldi, Larissa
    Corraes, Andre De Menezes Silva
    Parrondo, Ricardo
    Kapoor, Prashant
    Ailawadhi, Sikander
    Mas, Reyes
    Tamayo, Andrea
    Dimopoulos, Meletios
    Durie, Brian
    Martin, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S506 - S507
  • [9] Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience
    Trando, Aaron
    Ghamsari, Farid
    Yeung, Philip
    Costello, Caitlin
    Saunders, Ila
    Jeong, Ah-Reum
    BIOMEDICINES, 2025, 13 (01)
  • [10] Outcomes of ide-cel in patients with relapsed/refractory multiple myeloma: A single-institution experience
    Trando, Aaron
    Ghamsari, Farid
    Yeung, Philip
    Costello, Caitlin
    Saunders, Ila M.
    Jeong, Ah-Reum
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345